Fort Washington Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$133M Sell
2,304,823
-301,104
-12% -$17.3M 0.67% 32
2026
Q1
$158M Sell
2,605,927
-120,333
-4% -$7.01M 0.87% 25
2025
Q4
$147M Buy
2,726,260
+39,749
+1% +$1.91M 0.78% 30
2025
Q3
$121M Buy
2,686,511
+87,019
+3% +$4.06M 0.66% 34
2025
Q2
$120M Buy
2,599,492
+7,095
+0.3% +$348K 0.69% 34
2025
Q1
$158M Buy
2,592,397
+18,876
+0.7% +$1.1M 0.97% 27
2024
Q4
$146M Buy
2,573,521
+17,973
+0.7% +$1M 0.87% 29
2024
Q3
$132M Buy
2,555,548
+6,073
+0.2% +$285K 0.8% 32
2024
Q2
$106M Sell
2,549,475
-12,068
-0.5% -$540K 0.69% 35
2024
Q1
$139M Buy
2,561,543
+18,716
+0.7% +$953K 0.89% 29
2023
Q4
$130M Buy
2,542,827
+542,210
+27% +$28.5M 0.9% 29
2023
Q3
$116M Sell
2,000,617
-20,267
-1% -$1.24M 0.88% 30
2023
Q2
$129M Sell
2,020,884
-20,689
-1% -$1.39M 0.93% 29
2023
Q1
$142M Sell
2,041,573
-16,734
-0.8% -$1.18M 1.07% 26
2022
Q4
$148M Sell
2,058,307
-459,652
-18% -$34.7M 1.15% 23
2022
Q3
$179M Sell
2,517,959
-440,343
-15% -$31.9M 1.5% 15
2022
Q2
$228M Sell
2,958,302
-1,448,384
-33% -$110M 1.75% 10
2022
Q1
$322M Sell
4,406,686
-28,476
-0.6% -$1.91M 2.04% 7
2021
Q4
$277M Buy
4,435,162
+727,119
+20% +$42.7M 1.67% 10
2021
Q3
$219M Buy
3,708,043
+1,669,049
+82% +$110M 1.4% 17
2021
Q2
$136M Buy
2,038,994
+40,340
+2% +$2.63M 1.2% 23
2021
Q1
$126M Buy
1,998,654
+93,392
+5% +$5.81M 1.22% 22
2020
Q4
$118M Sell
1,905,262
-145,873
-7% -$8.97M 1.25% 20
2020
Q3
$124M Buy
2,051,135
+110,797
+6% +$6.67M 1.31% 16
2020
Q2
$114M Sell
1,940,338
-448
-0% -$26.8K 1.29% 15
2020
Q1
$108M Buy
1,940,786
+34,619
+2% +$2.12M 1.47% 14
2019
Q4
$122M Sell
1,906,167
-295,834
-13% -$16.9M 1.3% 16
2019
Q3
$112M Buy
2,202,001
+110,301
+5% +$5.18M 1.24% 17
2019
Q2
$94.9M Buy
2,091,700
+128,914
+7% +$6M 1.06% 24
2019
Q1
$93.6M Sell
1,962,786
-146,550
-7% -$7.3M 1.05% 24
2018
Q4
$110M Sell
2,109,336
-60,287
-3% -$3.24M 1.34% 15
2018
Q3
$135M Sell
2,169,623
-240,677
-10% -$14.3M 1.33% 16
2018
Q2
$133M Sell
2,410,300
-4,813
-0.2% -$260K 1.35% 12
2018
Q1
$153M Sell
2,415,113
-2,977
-0.1% -$192K 1.58% 9
2017
Q4
$148M Buy
2,418,090
+375,561
+18% +$23.5M 1.47% 10
2017
Q3
$130M Buy
2,042,529
+19,424
+1% +$1.13M 2.01% 9
2017
Q2
$113M Buy
2,023,105
+3,573
+0.2% +$194K 1.78% 14
2017
Q1
$111M Buy
2,019,532
+254,235
+14% +$13.9M 1.77% 15
2016
Q4
$103M Buy
1,765,297
+309,642
+21% +$16.9M 1.72% 15
2016
Q3
$78.5M Buy
1,455,655
+1,350,472
+1,284% +$86.7M 1.4% 20
2016
Q2
$7.74M Buy
105,183
+2,025
+2% +$143K 0.14% 102
2016
Q1
$6.59M Buy
103,158
+4,481
+5% +$283K 0.13% 108
2015
Q4
$6.79M Sell
98,677
-388
-0.4% -$25.6K 0.14% 107
2015
Q3
$5.87M Sell
99,065
-24,480
-20% -$1.55M 0.12% 116
2015
Q2
$8.22M Hold
123,545
0.15% 106
2015
Q1
$7.97M Buy
123,545
+851
+0.7% +$53.3K 0.16% 108
2014
Q4
$7.24M Hold
122,694
0.15% 112
2014
Q3
$6.28M Sell
122,694
-7,293
-6% -$364K 0.13% 122
2014
Q2
$6.31M Buy
129,987
+86,400
+198% +$4.26M 0.12% 144
2014
Q1
$2.26M Sell
43,587
-1,800
-4% -$95.8K 0.05% 199
2013
Q4
$2.41M Buy
45,387
+3,893
+9% +$198K 0.05% 235
2013
Q3
$1.92M Sell
41,494
-10,288
-20% -$452K 0.05% 274
2013
Q2
$2.31M Buy
+51,782
New +$2.25M 0.05% 250

Other funds holding BMY

Fort Washington Investment Advisors's BMY Position: Q2 2026 in Review

Fort Washington Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, selling an estimated $17.3M and leaving 2,304,823 shares worth $133M. The position accounts for 0.67% of the portfolio, ranked #32.

Fort Washington Investment Advisors first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $322M in Q1 2022. 1,031 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Fort Washington Investment Advisors held 2,304,823 shares of Bristol-Myers Squibb worth $133M as of Q2 2026.
  • Fort Washington Investment Advisors sold 301,104 Bristol-Myers Squibb shares in Q2 2026, an estimated $17.3M.
  • Bristol-Myers Squibb made up 0.67% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #32 holding.
  • Fort Washington Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Fort Washington Investment Advisors's Bristol-Myers Squibb position peaked at $322M in Q1 2022.
  • 1,031 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.